All In Biotech

Drug Trial Radar · NCT04947553

A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Dementia of the Alzheimer's Type

Last checked: Nov 19, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 456 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

456

Actual

Start

Jun 17, 2021

Primary completion

Dec 3, 2024

Study completion Dec 21, 2024

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 1, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 65 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety and efficacy of AXS-05 in subjects with Alzheimer's disease (AD) agitation.

Conditions

  • Agitation in Patients With Dementia of the Alzheimer's Type
  • Alzheimer Disease
  • Agitation, Psychomotor

Interventions

  • AXS-05 (dextromethorphan-bupropion)Drug

    AXS-05 tablets, taken twice daily

  • PlaceboDrug

    Placebo tablets, taken twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-term SafetyTime frame: up to 76 weeks
  2. Time to relapse of agitation symptomsTime frame: up to 24 weeks

Locations

47 sites in 3 countries. Site status is shown where the registry gives one.

  • Clinical Research Site

    Peoria, Arizona

  • Clinical Research Site

    Tempe, Arizona

  • Clinical Research Site

    Long Beach, California

  • Clinical Research Site

    Santa Ana, California

  • Clinical Research Site

    Temecula, California

  • Clinical Research Site

    Walnut Creek, California

  • Clinical Research Site

    Bonita Springs, Florida

  • Clinical Research Site

    Brandon, Florida

  • Clinical Research Site

    Coral Springs, Florida

  • Clinical Research Site

    Greenacres City, Florida

  • Clinical Research Site

    Hialeah, Florida

  • Clinical Research Site

    Hollywood, Florida

  • Clinical Research Site

    Kissimmee, Florida

  • Clinical Research Site

    Lake City, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami Gardens, Florida

  • Clinical Research Site

    Miami Lakes, Florida

  • Clinical Research Site

    Orlando, Florida

  • Clinical Research Site

    Pembroke Pines, Florida

  • Clinical Research Site

    Tampa, Florida

  • Clinical Research Site

    Tampa, Florida

  • Clinical Research Site

    Trinity, Florida

  • Clinical Research Site

    Columbus, Georgia

  • Clinical Research Site

    Wichita, Kansas

  • Clinical Research Site

    Braintree, Massachusetts

  • Clinical Research Site

    Flint, Michigan

  • Clinical Research Site

    Rochester Hills, Michigan

  • Clinical Research Site

    Chesterfield, Missouri

  • Clinical Research Site

    Toms River, New Jersey

  • Clinical Research Site

    Brooklyn, New York

  • Clinical Research Site

    New Windsor, New York

  • Clinical Research Site

    Staten Island, New York

  • Clinical Research Site

    Charlotte, North Carolina

  • Clinical Research Site

    Hickory, North Carolina

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.